Cargando…
Validation of The 3-Question Headache Screen in The Diagnosis of Migraine in Nigeria
BACKGROUND: Migraine is a chronic episodic disorder that is still under-diagnosed and undertreated. A rapid diagnostic method is desirable so that treatment can be initiated early. We compared the 3-question headache screen with the International Headache Society (IHS) criteria in the diagnosis of m...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research and Publications Office of Jimma University
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762953/ https://www.ncbi.nlm.nih.gov/pubmed/26949310 |
_version_ | 1782417171823984640 |
---|---|
author | Wahab, Kolawole Ugheoke, Asuwemhe Okokhere, Peter Ibekwe, Titus |
author_facet | Wahab, Kolawole Ugheoke, Asuwemhe Okokhere, Peter Ibekwe, Titus |
author_sort | Wahab, Kolawole |
collection | PubMed |
description | BACKGROUND: Migraine is a chronic episodic disorder that is still under-diagnosed and undertreated. A rapid diagnostic method is desirable so that treatment can be initiated early. We compared the 3-question headache screen with the International Headache Society (IHS) criteria in the diagnosis of migraine among Nigerians. METHODS: Using a multi-stage sampling technique, 1513 respondents were screened for migraine using both the IHS criteria and the 3-question headache screen. A statistical comparison of the two diagnostic methods was then done by determination of kappa coefficient, sensitivity and specificity. RESULTS: The prevalence of migraine obtained using the IHS criteria was 9.6% (95% CI, 8.1%–11.1%) while it was 8.3% (95% CI, 8.1%–8.5%) with the use of the 3-question headache screen. There was a good agreement between the IHS criteria and the 3-question headache screen (k=0.68, p<0.001). The 3-question headache screen had a sensitivity of 66.2% (95% CI, 58.5%–73.9%), specificity of 97.8% (95% CI, 97.0%–98.6%), positive predictive value of 76.2% (95% CI, 68.8%–83.6%) and a negative predictive value of 96.5% (95% CI, 95.5%–97.5%). CONCLUSION: The 3-question headache screen is sensitive and specific in making a rapid diagnosis of migraine among Nigerians. Its use is thus encouraged so that appropriate management of the condition can be initiated early in order to reduce associated disability. |
format | Online Article Text |
id | pubmed-4762953 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Research and Publications Office of Jimma University |
record_format | MEDLINE/PubMed |
spelling | pubmed-47629532016-03-04 Validation of The 3-Question Headache Screen in The Diagnosis of Migraine in Nigeria Wahab, Kolawole Ugheoke, Asuwemhe Okokhere, Peter Ibekwe, Titus Ethiop J Health Sci Original Article BACKGROUND: Migraine is a chronic episodic disorder that is still under-diagnosed and undertreated. A rapid diagnostic method is desirable so that treatment can be initiated early. We compared the 3-question headache screen with the International Headache Society (IHS) criteria in the diagnosis of migraine among Nigerians. METHODS: Using a multi-stage sampling technique, 1513 respondents were screened for migraine using both the IHS criteria and the 3-question headache screen. A statistical comparison of the two diagnostic methods was then done by determination of kappa coefficient, sensitivity and specificity. RESULTS: The prevalence of migraine obtained using the IHS criteria was 9.6% (95% CI, 8.1%–11.1%) while it was 8.3% (95% CI, 8.1%–8.5%) with the use of the 3-question headache screen. There was a good agreement between the IHS criteria and the 3-question headache screen (k=0.68, p<0.001). The 3-question headache screen had a sensitivity of 66.2% (95% CI, 58.5%–73.9%), specificity of 97.8% (95% CI, 97.0%–98.6%), positive predictive value of 76.2% (95% CI, 68.8%–83.6%) and a negative predictive value of 96.5% (95% CI, 95.5%–97.5%). CONCLUSION: The 3-question headache screen is sensitive and specific in making a rapid diagnosis of migraine among Nigerians. Its use is thus encouraged so that appropriate management of the condition can be initiated early in order to reduce associated disability. Research and Publications Office of Jimma University 2016-01 /pmc/articles/PMC4762953/ /pubmed/26949310 Text en Copyright © Jimma University, Research & Publications Office 2016 |
spellingShingle | Original Article Wahab, Kolawole Ugheoke, Asuwemhe Okokhere, Peter Ibekwe, Titus Validation of The 3-Question Headache Screen in The Diagnosis of Migraine in Nigeria |
title | Validation of The 3-Question Headache Screen in The Diagnosis of Migraine in Nigeria |
title_full | Validation of The 3-Question Headache Screen in The Diagnosis of Migraine in Nigeria |
title_fullStr | Validation of The 3-Question Headache Screen in The Diagnosis of Migraine in Nigeria |
title_full_unstemmed | Validation of The 3-Question Headache Screen in The Diagnosis of Migraine in Nigeria |
title_short | Validation of The 3-Question Headache Screen in The Diagnosis of Migraine in Nigeria |
title_sort | validation of the 3-question headache screen in the diagnosis of migraine in nigeria |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762953/ https://www.ncbi.nlm.nih.gov/pubmed/26949310 |
work_keys_str_mv | AT wahabkolawole validationofthe3questionheadachescreeninthediagnosisofmigraineinnigeria AT ugheokeasuwemhe validationofthe3questionheadachescreeninthediagnosisofmigraineinnigeria AT okokherepeter validationofthe3questionheadachescreeninthediagnosisofmigraineinnigeria AT ibekwetitus validationofthe3questionheadachescreeninthediagnosisofmigraineinnigeria |